Translational Microbiome Platform

Project Information

MICK

Grant agreement ID: 190195702

DOI 10.3030/190195702

Project closed

EC signature date 31 August 2022

Start date 1 September 2022

End date 28 February 2025

Funded under

• The European Innovation Council (EIC)

Total cost € 3 080 973,75

EU contribution € 2 156 681,63

Coordinated by

SEQUENTIA BIOTECH SL
Spain

Project description

Digital system for microbiome analysis to revolutionise clinical practice

Healthcare professionals will have help in integrating microbiome analysis into their clinical practice. The EU-funded MICK project will make this process more accessible and easier by automating the analysis process and providing evidence-based analytics, insights and practical recommendations in real time. As a unique solution, MICK system is user-friendly and cost-effective. Set to revolutionise the field of microbiome analysis and its application in the clinical setting, this digital decision-support system will provide accurate insights and analysis of microbiome raw data instantly. The project expects MICK system to help diagnostic labs and clinical centres scale their service offering to patients without any major investments.

Objective

Dysbiosis (the imbalance of the microbial community that resides within and upon us) can affect health and represents a risk factor for the genesis and evolution of a plethora of chronic diseases and pathologies. The analysis of the microbiome is necessary to detect, assess and monitor it. Nevertheless, microbiome analysis and its application to the clinical field is very complex, expensive, and time-consuming.
We created MICK, the first digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice. MICK automated platform analyses microbiome raw data in real-time, with the highest accuracy and translates it into evidence-based analytics, insights, and practical recommendations.
MICK allows customers (clinical centres and diagnostics labs) to scale their service offering to patients without any upfront investment, determining up to 75% cost reduction and faster TAT compared to existing solutions.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

• medical and health sciences › basic medicine › pathology
• natural sciences › biological sciences › microbiology

You need to log in or register to use this function

Keywords

• Bioinformatics
• Microbiology
• biotechnology
• ICT
• Health
• e-Health

Programme(s)

• HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
• HORIZON.3.1.2 - The Accelerator

Topic(s)

• HORIZON-EIC-2021-ACCELERATOROPEN-01 - EIC Accelerator Open 2021

Call for proposal

HORIZON-EIC-2021-ACCELERATOROPEN-01

Funding Scheme

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Coordinator

SEQUENTIA BIOTECH SL

• Net EU contribution: € 2 156 681,63
• Address: COMTE D'URGELL 240 3 D ; 08036 Barcelona ; Spain
• SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes:
  Region
  Este › Cataluña › Barcelona
• Region: Este › Cataluña › Barcelona
• Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Total cost: € 3 080 973,75